Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
about
Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomasKRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic valueMutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosaUnderstanding the interaction between environmental exposures and molecular events in colorectal carcinogenesis.High frequency of K-ras mutations in sporadic colorectal adenomas.Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidyDepletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications.Prospects for anti-ras drugs.EGFR Signaling in Colorectal Carcinoma.Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms.Role of proto-oncogene activation in carcinogenesis.Identification of potential synthetic lethal genes to p53 using a computational biology approachFrequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma.Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival.Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation.Over-expression of the c-myc proto-oncogene in colorectal carcinoma.KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review.A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma.K-ras mutations and HLA-DR expression in large bowel adenomasThe detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.Identification of DNA lesions using a third base pair for amplification and nanopore sequencing.Prognostic and predictive roles of KRAS mutation in colorectal cancer.Sequencing of DNA Lesions Facilitated by Site-Specific Excision via Base Excision Repair DNA Glycosylases Yielding Ligatable Gaps.Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.Protein hnRNP A1 and its derivative Up1 unfold quadruplex DNA in the human KRAS promoter: implications for transcriptionOrigins of ... flow cytometry and applications in oncologyColorectal cancer in review: the role of the EGFR pathway.Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.Codon 12 Ki-ras mutation in non-small-cell lung cancer: comparative evaluation in tumoural and non-tumoural lung.miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas.Ki-ras point mutations and proliferation activity in biliary tract carcinomas.Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia.Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells.Mutational frequency of KRAS, NRAS, IDH2, PIK3CA, and EGFR in North Indian gallbladder cancer patients.Molecular genetics of colorectal carcinoma.Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia.Clinical applications of the polymerase chain reaction.Quantitative proteomics reveals differentially expressed proteins in murine preneoplastic intestine in a model of intestinal tumorigenesis induced by low dietary folate and MTHFR deficiency.
P2860
Q24309208-29C28DA1-05B8-40E7-8AD8-EE73D90BD8DEQ33591865-BBB9867B-9A1C-435D-B547-E2C5F0BB61B1Q34099517-1D5025CD-D9BB-4DE8-833B-44F3194B8E1EQ34237543-078AC0D5-6037-4819-B479-CF5768DE185BQ34311096-918D8368-27E1-428F-9830-6FFD2D75566EQ34376472-53C440EB-48DC-4B2D-8FE2-C873EAF92D56Q34387134-7C567879-83B4-4D17-B7CD-BD0B18939864Q34516997-FECBAAC9-17AA-4924-A7D8-8E7F71EE73B0Q34534438-DDABEFDF-EED0-4425-998B-5E663C89E83AQ34627605-8257F200-1CB3-49F1-94BB-79FA21574495Q34810946-BB4300EC-73D6-4538-AEAD-109F593931BCQ34844276-F2086404-7285-48E1-97DF-48877BA47E28Q34985284-A9F2ED1A-C1DF-4DA9-A282-7D376D07D395Q35034184-B6E8F223-48F4-41AE-A939-8CD3113EE04EQ35587940-285C5345-5F7F-46C8-B740-32E30A2CCAFDQ35753502-5292B376-8A4D-4E7C-B8FE-AC5E772B4096Q35977137-DEB3DBE0-8C43-4E66-9B57-A8D4230AB8EAQ36102524-83359EAD-78CD-4AB2-AEAD-6122D2555EC8Q36116358-527516EC-5F78-410E-94DD-AFFB045504FDQ36135674-40DD35C0-54C5-42CA-B4AC-B022ED398858Q36292380-C2AB601A-5A3E-4F73-BF97-84ACDA8584D0Q36341399-603FEC6E-FAE3-480D-B396-ECFBA8DE2FD3Q36396396-EDF037C8-6180-413B-BBC7-3CED709828D1Q36790584-74C99DE6-76F5-4318-B2D6-26B45BB28961Q36882732-77A954BE-1351-4566-A0FC-C6F7B585B41DQ37199532-782A642C-E2CC-48EF-8C34-DA538C13F021Q37206535-0F38C3BF-53D0-4B07-929B-54BB538678C9Q37679938-95709E3F-4B3B-4E4C-A788-C7DC1C2B7A07Q38185970-C97C1974-A2E8-4BCC-B9C3-07575620C0D2Q39432515-A2124A00-E7F0-4EF9-90D2-15FFB00C73FEQ39482095-D79C7C90-2035-44EF-8556-8C2573BABB0BQ39527446-FDD9F1D0-0B85-4833-A6EC-57FE9FEC1218Q39999643-DB3D958E-6CF4-48D6-8AE4-3441C7DA8B1BQ40849338-E82DA10B-810E-4611-87AF-88739E3C2593Q40929368-490D3BB4-7D26-41A7-BA90-1A4CB300CD92Q41545847-733CECA7-AD4D-422F-A1EE-624E1D559258Q41927917-71020863-F4A8-4DFE-A3F0-39ACFC8EC3AEQ43500076-DA1A0909-3BDB-4B2C-8876-CEB812CC188CQ44986699-D7989C0B-183B-46AA-A4A2-B279D317CDA4Q46144544-E5DAF10A-7DC0-49F1-807B-D2895AF77128
P2860
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
name
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@ast
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@en
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@nl
type
label
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@ast
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@en
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@nl
prefLabel
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@ast
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@en
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@nl
P2860
P356
P1476
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.7.2403
P407
P577
1989-04-01T00:00:00Z